Intrathecal use of amikacin: a case report.
Meningitis caused by Acinetobacter baumannii is rare and are mostly hospital acquired after neurosurgical procedure. We report a case of a 40-year old man was admitted to the intensive care unit due to subarachnoid haemorrhage. Our patient developed a ventriculitis due to A.baumannii treated successfully with sulbactam IV and intrathecal amikacin.
Barrou
L
L
Reanimation Anaesthesia Department, Ibn Rochd University Hospital, Casablanca, Morocco.
Charra
B
B
Hachimi
A
A
Idali
B
B
Benslama
A
A
Motaouakkil
S
S
D000151:Acinetobacter Infections / Q000188:drug therapy* / Q000209:etiology; D040981:Acinetobacter baumannii; D000328:Adult; D000583:Amikacin / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003399:Craniotomy / Q000009:adverse effects; D017809:Fatal Outcome; D006801:Humans; D007278:Injections, Spinal; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000209:etiology; D013345:Subarachnoid Hemorrhage / Q000601:surgery; D013407:Sulbactam / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D000583:Amikacin; D013407:Sulbactam